Celgene Reports First Quarter 2016 Operating and Financial Results

Go back to Celgene Reports First Quarter 2016 Operating and Financial Results

Celgene (CELG) Tops Q1 EPS by 3c; Boosts Lower End of Outlook

April 28, 2016 7:32 AM EDT

Celgene (NASDAQ: CELG) reported Q1 EPS of $1.32, $0.03 better than the analyst estimate of $1.29. Revenue for the quarter came in at $2.51 billion versus the consensus estimate of $2.59 billion.

GUIDANCE:

Celgene sees FY2016 EPS of $5.60-$5.70, versus prior guidance of $5.50-$5.70 and... More